Securities Health Mergers & Acquisitions

Read need-to-know updates, commentary, and analysis on Securities issues written by leading professionals.
News & Analysis as of

Impact of the Cigna Health Decision on the Use of the Merger Structure in Private Acquisitions

When buying a private company controlled by a private equity sponsor but with a substantial number of other shareholders, a common technique to avoid the need to obtain signatures from all the shareholders to a stock purchase...more

Re-examining the M&A Playbook for Non-consenting Stockholders in Light of Cigna Health

In a case that is likely to impact M&A structuring for certain transactions, the Delaware Court of Chancery held that (1) stockholder release obligations found only in a letter of transmittal and not in the related merger...more

BIG DEAL MONDAY – Health Care REIT Announces Ambitious Investment Goal for Q1 2015

While 2015 has gotten off to something of a slow start in the number of deals closing, Health Care REIT has big plans for the early part of the year. Following its report of a record year of earnings to industry...more

California Healthcare Institute Releases 2015 California Biomedical Industry Report

The California Healthcare Institute and PricewaterhouseCoopers, LLP have released their 2015 California Biomedical Industry Report describing industry trends through 2014. The CHI report highlights the continued strength of...more

Health Headlines: Also in the News

Sixth Circuit Upholds FTC Decision to Block Hospital Merger – In an opinion issued last week, the Sixth Circuit Court of Appeals unanimously upheld the FTC’s decision that a 2010 merger in Lucas County, Ohio between...more

Matria Healthcare Insider Traders Will Go to Trial

The US District Court for the Northern District of Georgia denied a motion for partial summary judgment in the Security and Exchange Commission’s insider trading case against Earl Arrowood and Parker Petit. The SEC alleges...more

How to Minimize FCPA Risk in Health Care Acquisitions

When acquiring a health care company doing business abroad, there is no such thing as being too thorough with anti-corruption due diligence. The Department of Justice and the Securities and Exchange Commission have the...more

Pharmaceutical Anti-Corruption Compliance Conference In Philadelphia December 11-12

The pharmaceutical; medical device and medical supply industry have all been hit hard by Foreign Corrupt Practices Act (FCPA) enforcement actions. Just this summer, enforcement actions were announced against Pfizer which...more

China Life Sciences and Health Industry Client Briefing – September 2012 (October 4, 2012)

In This Issue: • Merck-Simcere Joint Venture Starts Business in Pudong (Shanghai Daily 2012-09-13) – September 14, 2012 • Pfizer Joint Venture Set to Hire 600 Staff (Bloomberg News 2012-09-14) – September 14,...more

Are Prosecutors Pushing the Envelope Too Far?

Federal prosecutors continue their aggressive enforcement of criminal laws against companies and individuals using aggressive investigative techniques, novel theories and new strategies which are testing the limits of due...more

Anti-Corruption Risks for Private Equity -- Portfolio Companies

The Justice Department and the SEC are targeting private equity companies for anti-corruption enforcement. Private equity companies are most at risk in their ownership of private equity companies....more

11 Results
|
View per page
Page: of 1

Follow Securities Updates on:

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:

Sign up to create your digest using LinkedIn*

*With LinkedIn, you don't need to create a separate login to manage your free JD Supra account, and we can make suggestions based on your needs and interests. We will not post anything on LinkedIn in your name. Or, sign up using your email address.
×